• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人神经母细胞瘤细胞系SK-N-SH纤溶酶原激活物的特性鉴定与部分纯化:与人类尿激酶的比较

Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.

作者信息

Gilbert L C, Wachsman J T

出版信息

Biochim Biophys Acta. 1982 Jun 24;704(3):450-60. doi: 10.1016/0167-4838(82)90067-x.

DOI:10.1016/0167-4838(82)90067-x
PMID:7052133
Abstract

The plasminogen activator liberated by cells of human neuroblastoma strain SK-N-SH was purified up to 400-fold, with a 40% recovery of activity, by a relatively simple procedure. This involved (NH4)2SO4 precipitation, followed by chromatography on both Affi-Gel Blue and p-aminobenzaminidine-Sepharose. The SK-N-SH activator was shown to differ from human urokinase with respect to immunological specificity, the molecular weights and isoelectric points of their enzymatically active species, the ability to be activated by fibrin and their relative sensitivities to inactivation by diisopropyl fluorophosphate. The average molecular weights of the enzymatically active species derived from strain SK-N-SH were shown to be 66,500, 64,500, 60,500 and 37,500. In the presence of fibrin, the SK-N-SH plasminogen activator appeared to be stimulated approximately 16-fold, with no apparent stimulation of urokinase activity. Urokinase is inactivated by diisopropyl fluorophosphate at a rate 6.4-fold faster than that of the SK-N-SH activator.

摘要

通过一个相对简单的程序,将人神经母细胞瘤SK - N - SH株细胞释放的纤溶酶原激活物纯化了400倍,活性回收率为40%。该程序包括硫酸铵沉淀,然后先后在Affi - Gel Blue和对氨基苯甲脒 - 琼脂糖上进行层析。结果表明,SK - N - SH激活物在免疫特异性、其酶活性形式的分子量和等电点、被纤维蛋白激活的能力以及它们对二异丙基氟磷酸失活的相对敏感性方面与人尿激酶不同。来自SK - N - SH株的酶活性形式的平均分子量显示为66,500、64,500、60,500和37,500。在有纤维蛋白存在的情况下,SK - N - SH纤溶酶原激活物似乎被刺激了约16倍,而尿激酶活性没有明显受到刺激。二异丙基氟磷酸使尿激酶失活的速度比SK - N - SH激活物快6.4倍。

相似文献

1
Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.人神经母细胞瘤细胞系SK-N-SH纤溶酶原激活物的特性鉴定与部分纯化:与人类尿激酶的比较
Biochim Biophys Acta. 1982 Jun 24;704(3):450-60. doi: 10.1016/0167-4838(82)90067-x.
2
Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.不同于尿激酶的人肾纤溶酶原激活物的纯化及特性研究
Biochim Biophys Acta. 1982 Aug 6;717(2):327-36. doi: 10.1016/0304-4165(82)90187-8.
3
Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.从培养的大鼠前列腺腺癌细胞中提取纤溶酶原激活剂及其性质
Biochemistry. 1983 Sep 13;22(19):4444-9. doi: 10.1021/bi00288a015.
4
Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.从大鼠吉田腹水肉瘤中分离纯化纤溶酶原激活剂。
Indian J Biochem Biophys. 1991 Feb;28(1):46-51.
5
Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.单链尿激酶原的蛋白水解切割会诱导构象变化,这种变化发生在酶原激活以及其对纤维蛋白的高亲和力降低之后。
J Biol Chem. 1985 Oct 5;260(22):12377-81.
6
Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea.
Exp Eye Res. 1979 Nov;29(5):563-71. doi: 10.1016/0014-4835(79)90156-8.
7
Plasminogen-activator in human early milk: its partial purification and characterization.人初乳中的纤溶酶原激活剂:其部分纯化及特性鉴定
Thromb Haemost. 1981 Apr 30;45(2):121-6.
8
Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.从培养的人内皮细胞中分离并鉴定出一种与尿激酶无法区分的尿激酶型纤溶酶原激活剂(分子量=54,000)。
J Biol Chem. 1984 Jun 10;259(11):7198-205.
9
Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.共价分子量约为92000的杂合型纤溶酶原激活剂,其来源于人纤溶酶氨基末端和尿激酶羧基末端结构域。
Biochemistry. 1986 Jun 17;25(12):3603-11. doi: 10.1021/bi00360a019.
10
Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case.源自一名肺癌患者的细胞系所分泌的异常高分子量的尿激酶样纤溶酶原激活剂。
J Biol Chem. 1982 May 25;257(10):5645-51.

引用本文的文献

1
Structural insights into the role of reduced cysteine residues in SOD1 amyloid filament formation.对SOD1淀粉样蛋白丝形成过程中还原型半胱氨酸残基作用的结构见解。
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2408582122. doi: 10.1073/pnas.2408582122. Epub 2025 Jan 28.
2
RT-qPCR for mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue.用于mRNA的逆转录定量聚合酶链反应(RT-qPCR)是评估睾丸组织中神经母细胞瘤微小残留病的一种高度特异且灵敏的方法。
Oncol Lett. 2017 Jul;14(1):860-866. doi: 10.3892/ol.2017.6238. Epub 2017 May 24.
3
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.
非精神活性大麻二酚在神经母细胞瘤中的体外和体内疗效
Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16.
4
Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma.载脂蛋白 A-I 包裹维甲酸用于神经母细胞瘤治疗的临床前评价。
Front Pediatr. 2013 Mar 21;1:6. doi: 10.3389/fped.2013.00006.
5
Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.人类脑肿瘤中纤溶酶原激活物抑制剂-1(PAI-1)水平升高。
J Neurooncol. 1993 Sep;17(3):215-21. doi: 10.1007/BF01049977.
6
Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Cancer Chemother Pharmacol. 1989;25(1):25-31. doi: 10.1007/BF00694334.